New Treatment
-
Leading new centre to strengthen cancer research and expertise
Posted on:
Researchers at the Kolling Institute have welcomed the launch of Australia’s premier cancer clinical trials centre on the Royal North Shore Hospital campus. NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg.
Category:
-
Innovative musculoskeletal program heads to the bush
Posted on:
In a sign of the strength of the Kolling Institute’s research and clinical capabilities, Professor Trudy Rebbeck has been awarded a $2.5 million grant to offer a musculoskeletal care program in rural and remote parts of Australia. As a Professor of Allied Health and a physiotherapist, Trudy will lead the collaborative project involving University of
-
Kolling Institute researchers instrumental in Australian first guidelines
Posted on:
It has taken three years and many hours of careful work, but two researchers from the John Walsh Centre for Rehabilitation Research have developed the first clinical practice guidelines for physiotherapists to inform the care of people with life-changing spinal cord injuries. Physiotherapy is a key part of rehabilitation for people with a spinal cord
-
Digital technology to support those with long-standing pain
Posted on:
Researchers based at the Kolling Institute have launched a clinical trial using digital health technology to help those with chronic pain reduce their use of opioids. Chief investigator and leading pain specialist at Royal North Shore Hospital Professor Paul Glare said many people with chronic pain are using opioid medications long-term, but research shows that
Category:
-
Combined digital interventions improve recovery following knee replacement surgery
Posted on:
For the thousands of people who undergo a total knee replacement each year, a new technological approach may hold the key to a better recovery following surgery. Researchers from the Kolling Institute conducted a randomized clinical trial, investigating whether a digital technology package delivered remotely was effective in reducing pain and improving mobility after a
Category:
-
Kolling researchers leading the fight against diabetes
Posted on:
With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease. Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated
-
Technology delivering support to those with back pain anywhere, any time
Posted on:
With the number of people living with low back pain escalating sharply, researchers are turning to widely-accessible technology to reduce the impact of the disabling condition. The team from the University of Sydney and the Kolling Institute has launched a study measuring the effectiveness of a mobile health program which offers self-management strategies via text
Category:
-
Australian researchers uniquely positioned to support upcoming space missions
Posted on:
The expertise across Australia’s space medicine community was showcased during a special event co-ordinated by the Kolling Institute and the Australasian Society of Aerospace Medicine. Staged over two days, the colloquium involved national and international experts including representatives from the Australian Space Agency, the CSIRO, Boeing and the Australian Antarctic Program. Presenters discussed the specific
Category:
-
A simple yet smart approach to spinal cord injuries may offer a new way forward
Posted on:
Researchers based at Royal North Shore Hospital have launched the first study of its kind in the world to support those with a spinal cord injury. The team from the Kolling Institute’s John Walsh Centre for Rehabilitation Research is now seeking recruits for the clinical trial which is investigating the benefits of an approach combining
Category:
-
New approach revolutionising ovarian cancer research
Posted on:
With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope. The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis. Ovarian cancer is often diagnosed late because the symptoms are
Category:
Copyright © 2026 Kolling Institute
All rights reserved